Intercept’s NASH dreams may be dashed after FDA panel votes against Ocaliva’s approval bid fkansteiner Fri, 05/19/2023 – 17:30 More: Intercept's NASH dreams may be dashed after FDA panel votes against Ocaliva's approval bid Source: fierce
read moreKrystal’s Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease zbecker Fri, 05/19/2023 – 16:25 More: Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease Source: fierce
read moreAbbVie, Genmab’s lymphoma drug Epkinly snags FDA approval in heated blood cancer race aliu Fri, 05/19/2023 – 11:21 More: AbbVie, Genmab's lymphoma drug Epkinly snags FDA approval in heated blood cancer race Source: fierce
read moreAs Catalent delays earnings again, CEO notes financial performance has fallen ‘significantly short’ fkansteiner Fri, 05/19/2023 – 11:14 More: As Catalent delays earnings again, CEO notes financial performance has fallen 'significantly short' Source: fierce
read moreAt request of FTC, Amgen agrees to delay closure of $27.8B Horizon acquisition until September kdunleavy Fri, 05/19/2023 – 10:35 More: At request of FTC, Amgen agrees to delay closure of .8B Horizon acquisition until September Source: fierce
read moreTreatment concerns up to 150,000 patients in England with chronic heart failure More: AstraZeneca’s dapagliflozin recommended by NICE Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals